Veeda Group Acquires European CRO Heads

Join us as we embark on an exhilarating journey of innovation and excellence in delivering end-to-end drug development services on a global scale.
We cordially invite you to watch and listen to our Group CEO, Dr. Mahesh Bhalgat, as he shares insightful comments on Veeda's recent acquisition of Health Data Specialists (Heads), a Europe-based CRO recognized as a global leader in Oncology Trials.
With Heads now part of the Veeda Group, we're well-positioned to harness our collective strengths to advance drug development, foster equitable trial access, and accelerate the development of innovative medications that enhance patient care on a global scale.
As we move forward, we're excited about the integration and the global reach that the acquisition brings.